Losartan (Cozaar) will be promoted to prevent stroke
May 2003
Losartan (Cozaar) will be promoted to prevent stroke.
The FDA just approved this new indication for patients with hypertension and left ventricular hypertrophy (LVH).
LVH is a risk factor for stroke. Hypertensive patients with LVH have about twice the risk of stroke as those without it.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote